Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Samir Parekh, Charles Gleason et al.|Cancer Cell|2021Cited by 216
<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid TumorsElio Adib, David J. Kwiatkowski, Amin H. Nassar et al.|Clinical Cancer Research|2021Cited by 129
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H. Nassar, Alexander Gusev, Christopher J. Fong et al.|Cancer Cell|2022Cited by 117
Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapyOliver Van Oekelen, Samir Parekh, Karthik Nath et al.|Blood|2022Cited by 103
Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid TumorsSarah Abou Alaiwi, Toni K. Choueiri, Amin H. Nassar et al.|Cancer Immunology Research|2020Cited by 79